, Pertussis vaccines: WHO position paper, Wkly Epidemiol Rec, vol.85, pp.385-400, 2010.

E. L. Hewlett and K. M. Edwards, Clinical practice. Pertussis -not just for kids, N Engl J Med, vol.352, pp.1215-1237, 2005.

B. M. Althouse and S. V. Sarpino, Asymptomatic transmission and the resurgence of Bordetella pertussis, BMC Med, vol.13, p.146, 2015.

K. Rubin and S. Glazer, Potential role of Bordetella pertussis in celiac disease, Intl J Celiac Dis, vol.3, pp.75-81, 2015.

K. Rubin and S. Glazer, The potential role of subclinical Bordetella pertussis colonization in the etiology or multiple sclerosis, Immunobiology, vol.221, pp.512-517, 2016.

K. Rubin and S. Glazer, The pertussis hypothesis: Bordetella pertussis colonization in the pathogenesis of Alzheimer's disease, Immunobiology, vol.222, pp.228-268, 2017.

J. Storsaeter, J. Wolter, and C. Locht, Pertussis vaccines, Bordetella Molecular Microbiology, pp.245-88, 2007.

J. M. Warfel, L. I. Zimmerman, and T. J. Merkel, Acellular pertussis vaccines protect against disease but fail to prevent infection and transmission in a nonhuman primate model, Proc Natl Acad Sci, vol.111, pp.787-92, 2014.

N. Mielcarek, A. S. Debrie, D. Raze, J. Bertout, C. Rouanet et al., Live attenuated B. pertussis as a single-dose nasal vaccine against whooping cough, PLoS Pathog, vol.2, p.65, 2006.

C. M. Skerry, J. P. Cassidy, K. English, P. Feunou-feunou, C. Locht et al., A live attenuated Bordetella pertussis candidate vaccine does not cause disseminating infection in gamma interferon receptor knockout mice, Clin Vaccine Immunol, vol.16, pp.1344-51, 2009.

J. J. Munoz, C. C. Bernard, and I. R. Mackay, Elicitation of experimental allergic encephalomyelitis (EAE) in mice with the aid of pertussigen, Cell Immunol, vol.83, pp.92-100, 1984.

P. F. Feunou, J. Ismaili, A. S. Debrie, L. Huot, D. Hot et al., Genetic stability of the live attenuated Bordetella pertussis vaccine candidate BPZE1, Vaccine, vol.26, pp.5722-5729, 2008.

P. F. Feunou, H. Kammoun, A. S. Debrie, N. Mielcarek, and C. Locht, Long-term immunity against pertussis induced by a single nasal administration of live attenuated B. pertussis BPZE1, Vaccine, vol.28, pp.7047-53, 2010.

P. F. Feunou, J. Bertout, and C. Locht, T-and B-cell-mediated protection induced by novel, live attenuated pertussis vaccine in mice cross protection against parapertussis, PLoS ONE, vol.5, p.10178, 2010.

C. M. Skerry and B. P. Mahon, A live, attenuated Bordetella pertussis vaccine provides long-term protection against virulent challenge in a murine model, Clin Vaccine Immunol, vol.18, pp.187-93, 2011.

C. Locht, J. F. Papin, S. Lecher, A. S. Debrie, M. Thalen et al., Live attenuated pertussis vaccine BPZE1 protects baboons against Bordetella pertussis disease and infection, J Infect Dis, vol.216, pp.117-141, 2017.

R. Thorstensson, B. Trollfors, N. Al-tawil, M. Jahnmatz, J. Bergström et al., A phase I clinical study of a live attenuated Bordetella pertussis vaccine -BPZE1; a single centre, double-blind, placebo-controlled, dose-escalating study of BPZE1 given intranasally to healthy adult male volunteers, PLoS ONE, vol.9, p.83449, 2014.

J. Parkhill, M. Sebaihia, A. Preston, L. D. Murphy, N. Thomson et al., Comparative analysis of the genome sequences of Bordetella pertussis, Bordetella parapertussis and Bordetella bronchiseptica, Nat Genet, vol.35, pp.32-40, 2003.

A. J. Schmidtke, K. O. Boney, S. W. Martin, T. H. Skoff, M. L. Tondella et al., Population diversity among Bordetella pertussis isolates, Emerg Infect Dis, vol.18, pp.1248-55, 2012.

M. Van-gent, C. J. Heuvelman, H. G. Van-der-heide, H. O. Hallander, A. Advani et al., Analysis of Bordetella pertussis clinical isolates circulating in European countries during the period 1998-2012, Eur J Clin Microbiol Infect Dis, vol.34, pp.821-851, 2015.

A. Robinson, A. R. Gorringe, S. G. Funnell, and M. Fernandez, Serospecific protection of mice against intranasal infection with Bordetella pertussis, Vaccine, vol.7, pp.321-325, 1989.

A. Imaizumi, Y. Suzuki, S. Ono, H. Sato, and Y. Sato, Effect of heptakis(2,6-Odimethyl)ß-cyclodextrin on the production of pertussis toxin by Bordetella pertussis, Infect Immun, vol.41, pp.1138-1181, 1983.

M. Thalen, J. Van-den-ijssel, W. Jiskoot, B. Zomer, P. Roholl et al., Rational medium design for Bordetella pertussis: basic metabolism, J Biotechnol, vol.75, pp.147-59, 1999.

R. Antoine, I. Huvent, K. Chemlal, I. Deray, D. Raze et al., The periplasmic binding protein of a tripartite tricarboxylate transporter is involved in signal transduction, J Mol Biol, vol.351, pp.799-809, 2005.

F. D. Menozzi, R. Mutombo, G. Renauld, G. Gantiez, J. H. Hannah et al., Heparin-inhibitable lectin activity of the filamentous hemagglutinin adhesin of Bordetella pertussis, Infect Immun, vol.62, pp.769-78, 1994.

R. Simon, U. Preifer, and A. Puhler, A broad host range mobilization system for in vivo genetic engineering : transposon mutagenesis in gram negative bacteria, Bio/Technology, vol.1, pp.784-91, 1983.

F. R. Mooi, I. H. Van-loo, M. Van-gent, Q. He, M. J. Bart et al., Bordetella pertussis strains with increased toxin production associated with pertussis resurgence, Emerg Infect Dis, vol.15, pp.1206-1219, 2009.

F. R. Mooi, H. Van-oirschot, K. Van-der-heuvelman, H. G. Heide, W. Gaastra et al., Polymorphism in the Bordetella pertussis virulence factors P.69/pertactin and pertussis toxin in the Netherlands: temporal trends and evidence for vaccine-driven evolution, Infect Immun, vol.66, pp.670-675, 1998.

F. Alexander, M. Matheson, N. K. Fry, B. Labram, and A. R. Gorringe, Antibody responses to individual Bordetella pertussis fimbrial antigen Fim2 or Fim3 following immunization with the five-component acellular pertussis vaccine or to pertussis disease, Clin Vaccine Immunol, vol.19, pp.1776-83, 2012.

R. J. Willems, A. Paul, H. G. Van-der-heide, A. R. Ter-avest, and F. R. Mooi, Fimbrial phase variation in Bordetella pertussis: a novel mechanism for transcriptional regulation, EMBO J, vol.9, pp.2803-2812, 1990.

Q. Chen, K. B. Decker, P. E. Boucher, D. Hinton, and S. Stibitz, Novel architectural features of Bordetella pertussis fimbrial subunit promoters and their activation by the global virulence regulator BvgA, Mol Microbiol, vol.77, pp.1326-1366, 2010.

A. Robinson, L. A. Ashworth, and L. I. Irons, Serotyping Bordetella pertussis strains, Vaccine, vol.7, pp.491-495, 1989.

M. E. Rodriguez, S. M. Hellwig, P. Vidakovics, M. L. Berbers, G. A. Van-de-winkel et al., Bordetella pertussis attachment to respiratory epithelial cells can be impaired by fimbriae-specific antibodies, FEMS Immunol Med Microbiol, vol.46, pp.39-47, 2006.

C. Guevara, C. Zhang, J. A. Gaddy, J. Iqbal, J. Gerra et al., Highly differentiated human airway epithelial cells: a model to study host cellparasite interactions in pertussis, Infect Dis, vol.48, pp.177-88, 2016.

N. W. Preston, Prevalent serotypes of Bordetella pertussis in non-vaccinated communities, J Hyg, vol.77, pp.85-91, 1976.

. Medical-research and . Council, Vaccination against whooping-cough : relation between protection in children and results of laboratory tests, Brit Med J, vol.2, pp.454-62, 1956.

F. Alexander, M. Matheson, and N. K. Fry, Antibody responses to individual Bordetella pertussis fimbrial antigen Fim2 or Fim3 following immunization with the five-component acellular pertussis vaccine or pertussis disease, Clin Vaccine Immunol, vol.19, pp.1776-83, 2012.

, WHO Expert committee on biological standartization. Thirtieth report. World Health Organ Tech Rep Ser, vol.638, pp.61-66, 1979.

P. Olin, F. Rasmussen, L. Gustafsson, H. O. Hallander, and H. Heijbel, Ad hoc group for the study of pertussis vaccines. Randomised controlled trial of twocomponent, three-component, and five-component acellular pertussis vaccines compared with whole-cell pertussis vaccine, Lancet, vol.350, pp.1569-77, 1997.

J. Storsaeter, H. O. Hallander, L. Gustafsson, and P. Olin, Levels of anti-pertussis antibodies related to protection after household exposure to Bordetella pertussis, Vaccine, vol.16, issue.20, pp.1907-1923, 1998.

E. R. Packard, R. Parton, J. G. Coote, and N. K. Fry, Sequence variation and conservation in virulence-related genes of Bordetella pertussis isolates from the UK, J Med Microbiol, vol.53, pp.355-65, 2004.

F. R. Mooi, Bordetella pertussis and vaccination : the persistence of a genetically monomorphic pathogen, Infect. Genet Evol, vol.10, pp.36-49, 2010.

R. S. Tsang, A. K. Lau, M. L. Sill, S. A. Halperin, P. Van-caeseele et al., Polymorphisms of the fimbria fim3 gene of Bordetella pertussis strains isolated in Canada, J Clin Microbiol, vol.42, pp.5364-5371, 2004.

N. W. Preston, R. M. Timewell, and E. J. Carter, Experimental pertussis infection in the rabbit: similarities with infection in primates, J Infect, vol.2, pp.227-262, 1980.

S. Stibitz, The bvg regulon, Bordetella Molecular Microbiology, pp.47-67, 2007.

M. P. Carlos and J. H. Miller, Genetic and sequences analysis of frameshift mutations induced by ICR-191, J Mol Biol, vol.153, pp.39-66, 1981.